Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02998047
Brief Title: A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma

First Submitted : December 12, 2016
First Submitted that Met QC Criteria : December 16, 2016
First Posted : December 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 22, 2020
Last Update Posted : May 26, 2020